Silverleafe Capital Partners, LLC Dexcom Inc Transaction History

Silverleafe Capital Partners, LLC

  • $279 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 02, 2020
SELL
$36.62 - $57.29 $844,347 - $1.32 Million
-23,057 Closed
0 $0
Q3 2019

Oct 04, 2019
BUY
$35.53 - $43.8 $706,762 - $871,269
19,892 Added 628.5%
23,057 $3.44 Million
Q2 2019

Jul 03, 2019
BUY
$27.84 - $38.92 $88,113 - $123,181
3,165 New
3,165 $474,000

Others Institutions Holding DXCM

# of Institutions
1,014
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Silverleafe Capital Partners, LLC Portfolio

Follow Silverleafe Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverleafe Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverleafe Capital Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email